| Cell line name | PFIZi021-A |
|---|---|
| Synonyms | OD001-S7 |
| Accession | CVCL_RF99 |
| Resource Identification Initiative | To cite this cell line use: PFIZi021-A (RRID:CVCL_RF99) |
| Comments | From: Pfizer, Inc. |
| Sequence variations | Heterozygous for SCN1A p.Thr1721Lys (c.5162C>A) (ClinVar=VCV000206859); de novo mutation (hPSCReg). |
| Disease | Early infantile epileptic encephalopathy 6 (NCIt: C147071) Dravet syndrome (ORDO: Orphanet_33069) |
| Species of origin | Homo sapiens (Human)
(NCBI Taxonomy: 9606)
|
| Sex of cell | Male |
| Age at sampling | 10-14Y |
| Category | Induced pluripotent stem cell |
| Cross-references | |
| Cell line collections | EBiSC; PFIZi021-A |
| Cell line databases/resources | hPSCreg; PFIZi021-A |
| Biological sample resources | BioSamples; SAMEA4563388 |
| Other | Wikidata; Q54947276 |
| Entry history | |
| Entry creation | 05-Mar-2018 |
| Last entry update | 02-Jul-2020 |
| Version number | 5 |